Showing 3 posts of 3 posts found.

Researchers make neuroblastoma drug target discovery

February 8, 2021
Sales and Marketing Cancer, GOSH, neuroblastoma

Scientists conducting the largest single cell study to date of the childhood cancer neuroblastoma have made a breakthrough in identifying …

NICE approves treatment for rare and deadly childhood cancer

July 11, 2018
Sales and Marketing Cancer, NICE, UK, neuroblastoma, pharma

NICE has recommended that monoclonal antibody dinutuximab beta be used in treating high-risk neuroblastoma – a rare and deadly form …

Nice rejects United Therapeutics’ cancer drug

July 15, 2016
Medical Communications, Research and Development NICE, United Therapeutics, Unituxin, neuroblastoma

The National Institute for Health and Care Excellence (Nice) rejected United Therapeutics’ (Nasdaq: UTHR) Unituxin (dinutuximab) in combination therapy to …

Latest content